Back to today’s briefing

Story perspectives

Study Reveals 44% Fracture Risk Reduction for Postmenopausal Women

1/17/2025

50 5

Summary

Story summary

A groundbreaking 10-year study from the University of Auckland, led by Mark Bolland, reveals that early postmenopausal women who receive zoledronate infusions every five years can slash their risk of vertebral fractures by an impressive 41-44%. This promising treatment provides a vital preventive option for women facing low to moderate fracture risks.

1 of 1

Story summary

A groundbreaking 10-year study from the University of Auckland, led by Mark Bolland, reveals that early postmenopausal women who receive zoledronate infusions every five years can slash their risk of vertebral fractures by an impressive 41-44%. This promising treatment provides a vital preventive option for women facing low to moderate fracture risks.